PTGS2 and breast carcinoma: While prior studies have established that COX-2 secretion by breast cancer cells can upregulate CCR7 expression via activation of EP2/EP4 receptors [20,36] to enhance their invasive capacity, a possible link between CCR7 signaling and VEGF-C expression/secretion has remained untested so far.